Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci

Infection and Immunity

Volumn 69, Issue 4, 2001, Pages 2302-2308

  Cheng, Q ^a   Carlson, B ^a   Pillai, S ^a   Eby, R ^a   Edwards, L ^a   Olmsted, S B ^a   Cleary, P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CD11B ANTIGEN; CD14 ANTIGEN; CELL SURFACE PROTEIN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A PEPTIDASE; POLYSACCHARIDE VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGENICITY; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; SEROTYPE; STREPTOCOCCUS AGALACTIAE; VACCINE PRODUCTION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; ENDOPEPTIDASES; FEMALE; IMMUNIZATION; MACROPHAGES; MICE; NEUTROPHILS; PHAGOCYTOSIS; RESPIRATORY BURST; STREPTOCOCCUS AGALACTIAE;

EID: 0035077539     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.4.2302-2308.2001     Document Type: Article

References (40)

1. Nonopsonic binding of type III group B streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway
2. Opsonin-independent phagocytosis of group B streptococci: Role of complement receptor type three
3. Group B streptococcal infections
4. 1997 AAP guidelines for prevention of early-onset group B streptococcal disease
5. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection
6. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib
7. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci
8. Antibodies to group B streptococci in neonates and infants
9. A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections
10. Consideration of the C5a peptidase genes in group A and B streptococci
11. Structural and functional similarity of C5a-ase enzymes from group A and B streptococci
12. Group B streptococci persist inside macrophages
13. Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus
14. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines
15. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence
16. Effect of surfactant on nitroblue tetrazolium reduction of polymorphonuclear leucocytes stimulated with type la group B streptococci
17. Changing epidemiology of group B streptococcal colonization
18. Group B streptococci inhibit the chemotactic activity of the fifth component of complement
19. Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture
20. Phagocytosis of the Legionnaires disease bacterium (Legionella pneumophila) occurs by a novel mechanism: Engulfment within a pseudopod coil
21. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococcus
22. Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes
23. Current knowledge of the type specific M antigens of group A streptococci
24. Experimental vaccination against group B streptococcus, and encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha
25. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine
26. Antibody-independent and -dependent opsonization of group B streptococcus requires the first component of complement C1
27. Maternal immunization of alice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes
28. Survival of group B streptococcus type III in mononuclear phagocytes: Differential regulation of bacterial killing in cord macrophages by human recombinant gamma interferon and granulocyte-macrophage colony stimulating factor
29. Induction of macrophagic and granulocytic differentiation of murine bone marrow progenitor cells by 1, 25-dihydroxyvitamin D3
30. Immunogenic correlation between cross-reacting material (CRM97) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid
31. Antibacterial activity of human mononuclear leukocytes against Staphylococcus aureus
32. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
33. Role of antibody and complement in opsonization of group B streptococci
34. C5a peptidase gene from group B streptococci
35. Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci
36. Action and production of diphtheria toxin, with special reference to its analysis using the cross-reacting toxin material
37. Entry and intracellular survival of group B streptococci in J774 macrophages
38. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci
39. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B streptococcus
40. A streptococcal inactivator of chemotaxis: A new virulence factor specific to group A streptococci